| 2025 | 2024 | 2023 | 2022 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 436,4 k € | +7.5% | 406,0 k € | +7.8% | 376,8 k € | -4.7% | 395,4 k € | +144.1% | 162,0 k € | +6.9% | 151,5 k € | +10.6% | 137,0 k € | -10.8% | 153,6 k € | -43.5% | 272,1 k € | +22.3% | 222,5 k € | +0.6% | 221,2 k € | +30.7% | 169,3 k € | +20.2% | 140,8 k € | +3.7% | 135,8 k € | -6.8% | 145,7 k € | +3.3% | 141,0 k € | |
| EBITDA | 114,4 k € | +36.4% | 83,9 k € | +9.3% | 76,8 k € | -40.8% | 129,7 k € | +158.0% | 50,3 k € | -15.6% | 59,5 k € | -18.9% | 73,4 k € | -22.4% | 94,6 k € | -50.6% | 191,3 k € | +40.2% | 136,4 k € | -7.9% | 148,0 k € | +27.6% | 116,0 k € | +9.7% | 105,8 k € | +0.4% | 105,3 k € | -2.4% | 107,9 k € | +12.7% | 95,7 k € | |
| Operating profit | 74,8 k € | +67.0% | 44,8 k € | +16.2% | 38,6 k € | -60.0% | 96,3 k € | +24101.9% | 398,0 € | -98.8% | 32,1 k € | -38.6% | 52,2 k € | +44.6% | 36,1 k € | -75.7% | 148,8 k € | +89.1% | 78,7 k € | +5.7% | 74,5 k € | +149.9% | 29,8 k € | -40.3% | 49,9 k € | +16.2% | 43,0 k € | -8.6% | 47,0 k € | -0.1% | 47,1 k € | |
| Profit/loss | 45,5 k € | +215.2% | 14,4 k € | -16.3% | 17,2 k € | -78.5% | 80,0 k € | +895.9% | -10,1 k € | -147.3% | 21,3 k € | -32.0% | 31,2 k € | +47.0% | 21,3 k € | -75.5% | 86,7 k € | +157.7% | 33,7 k € | +2.1% | 33,0 k € | +103.9% | 16,2 k € | -14.8% | 19,0 k € | -8.1% | 20,7 k € | -27.2% | 28,4 k € | +32.0% | 21,5 k € | |
| Equity | 365,9 k € | +0.1% | 365,5 k € | +2.4% | 357,1 k € | +2.9% | 346,9 k € | -13.1% | 399,1 k € | -2.5% | 409,1 k € | +1.1% | 404,7 k € | +8.4% | 373,4 k € | +7.9% | 346,0 k € | +33.5% | 259,2 k € | +14.9% | 225,6 k € | +17.1% | 192,6 k € | +9.2% | 176,4 k € | +12.1% | 157,5 k € | +15.1% | 136,8 k € | +26.2% | 108,4 k € | |
| Total assets | 1,2 M € | +5.6% | 1,1 M € | +1.9% | 1,1 M € | -10.1% | 1,2 M € | +16.4% | 1,1 M € | +12.2% | 945,4 k € | +1.8% | 928,3 k € | +8.8% | 853,1 k € | +60.2% | 532,5 k € | -46.9% | 1,0 M € | +11.1% | 902,3 k € | +12.1% | 804,6 k € | +92.1% | 418,9 k € | +8.9% | 384,6 k € | -19.2% | 476,0 k € | -30.0% | 679,9 k € | |
| Cash | 186,8 k € | -5.9% | 198,6 k € | +46.4% | 135,6 k € | -45.4% | 248,6 k € | +25.6% | 198,0 k € | +37.6% | 143,9 k € | -26.3% | 195,3 k € | +41.9% | 137,6 k € | +29.2% | 106,5 k € | -60.9% | 272,2 k € | -20.0% | 340,5 k € | +100.3% | 169,9 k € | -8.0% | 184,8 k € | +101.9% | 91,6 k € | -33.5% | 137,7 k € | -65.1% | 394,6 k € | |
| Debts | 810,9 k € | +8.0% | 751,2 k € | +1.0% | 743,7 k € | -16.0% | 885,1 k € | +36.3% | 649,6 k € | +21.1% | 536,3 k € | +4.0% | 515,4 k € | +7.5% | 479,7 k € | +175.9% | 173,8 k € | -74.3% | 677,0 k € | +8.2% | 625,7 k € | +4.6% | 598,0 k € | +160.1% | 229,9 k € | +9.7% | 209,7 k € | -33.9% | 316,9 k € | -41.7% | 543,9 k € | |
| Staff | 4,6 | 4,7 | 4,4 | 4,9 | 2,9 | 1,1 | 1,1 | 1,1 | 1,5 | 1,7 | 1,6 | 1,1 | 0,6 | 0,5 | 0,8 | 0,9 | ||||||||||||||||
Private limited company · Nazareth-De Pinte · incorporated on 31/12/2001 · 4,6 ETP
Private limited company profitable and well capitalised. Cash position declining (-5.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK PHARMAGO is a Private limited company incorporated in 2001. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Nazareth-De Pinte. It employs on average 4,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette